Table 2. Patient and tumor characteristics of all liver recipients (n = 93) according to pretransplant IBT.

Variable	IBT	non-IBT	P-value
	(n = 59)	(n = 34)
Age recipient at LT (y)	58.1±6.7	58.4±7.5	0.84
Age donor at LT (y)	50.8±14.1	46.2±14.5	0.14
Child status (n)			0.86
A	30	18
B or C	29	16
Waiting time prior LT (months)	6.1±3,2	6.6±4.0	0.54
Liver allograft (n)			0.37
deceased	52	29
living related	´7	6
Mean AFP level at LT (ng/ml)	1012±6127	903±2509	0.92
*Mean number tumor nodules (n, range)	2.2±1.6 (1–8)	1.5±1.1 (1–5)	0.03
*Mean diameter largest tumor nodule (cm)	4.0±2.1	4.6±3.5	0.30
*Mean total tumor diameter (cm)	6.5±4.0	6.2±4.5	0.69
*Milan status (n)			0.71
In	37	20
Out	22	14
*UCSF status (n)			0.91
In	41	24
Out	18	10
PET + status (n)	40	18	0.51
Poor tumor differentiation (n)	9	8	0.32
Major vascular invasion (n)	1	3	0.11
Lymphatic vascular invasion (n)	8	9	0.12
Immunosuppression (n)			0.02
CsA	18	19
Tac	41	15

^*based on final pretransplant clinical staging.

AFP: alpha-fetoprotein.

Tac: tacrolimus.

PET: positron emission tomography.

UCSF: University of California San.

CsA: cyclosporine A.

Francisco.